CGS: Broader Perspective Needed in IOM-CIRM Performance Evaluation
The Center for Genetics and Society has filed a brief statement with the Institute of Medicine panel examining the performance of the California stem cell agency, expressing the hope that the inquiry will include "a broader range of sources."
Marcy Darnovsky, associate executive director of the Berkeley group, said that "a meaningful review by (the IOM) …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.